封面
市場調查報告書
商品編碼
1890958

血脂檢查市場:依檢測類型、產品類型、應用、配方、最終用戶和地區分類

Lipid Panel Test Market, By Test Type, By Product Type, By Application, By Prescription Mode, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年,血脂檢查市場規模將達到 118.2 億美元,到 2032 年將達到 201.3 億美元,2025 年至 2032 年的複合年成長率為 7.9%。

報告內容 報告詳情
基準年: 2024 2025年市場規模: 118.2億美元
歷史數據時期: 2020年至2024年 預測期: 2025年至2032年
預測期(2025-2032年)複合年成長率: 7.90% 2032 年的預測值: 201.3億美元

全球血脂檢查市場是臨床診斷行業的重要組成部分,包括測量各種膽固醇和三酸甘油酯水平以評估心血管疾病風險的綜合血液檢測。血脂檢查(也稱為血脂譜或血脂圖)評估患者血液樣本中的總膽固醇、低密度脂蛋白膽固醇 (LDL)、高密度脂蛋白膽固醇 (HDL) 和三酸甘油酯。

這些診斷評估是基本的篩檢工具,可幫助醫療保健提供者識別有動脈粥狀硬化、冠狀動脈疾病和其他心血管併發症的個體。市面上的檢測方法多種多樣,包括酵素法、均相法和先進的自動化分析儀,並已應用於醫院、診斷檢查室和照護現場機構。

隨著文明病的增加、人口老化以及人們對預防性醫療保健措施意識的提高,全球對血脂檢查的需求持續成長。高通量分析儀、攜帶式檢測設備和數位健康平台等技術創新的融合,顯著提高了血脂檢測的可及性和效率,使其在世界各地的各種醫療機構中都能為醫護人員和患者帶來更多便利。

市場動態

全球血脂檢查市場成長的主要驅動力是心血管疾病、糖尿病和肥胖症的日益流行,這顯著增加了對定期血脂監測和篩檢的需求。人口老化,尤其是在已開發國家,也對市場成長做出了重要貢獻,因為老年人需要頻繁進行心血管風險評估和血脂監測。

診斷設備的科技進步,特別是高通量自動化分析儀、就地檢驗設備和攜帶式血脂檢測解決方案的開發,提高了檢測的準確性、效率和可及性,從而推動了市場擴張。政府為促進預防性醫療保健措施、心血管疾病篩檢計畫和健康意識宣傳活動採取的舉措,也進一步刺激了市場需求。

然而,先進診斷設備和檢測程序的高成本是限制因素之一,這可能會限制資源匱乏的醫療機構和發展中地區的醫療服務取得。診斷設備核准、品管標準和檢查室認證的嚴格監管要求構成市場准入壁壘,並增加了製造商的合規成本。此外,某些地區醫療基礎設施不足、熟練實驗室技術人員短缺以及報銷政策不完善也阻礙了市場成長。

然而,新興市場蘊藏著巨大的機遇,這得益於醫療基礎設施的不斷改善、醫療支出的成長以及人們對心血管健康的日益意識提升。人工智慧、機器學習演算法和遠端醫療平台的融合,為開發創新血脂檢測解決方案和遠端監測功能提供了契機。居家醫療和自我管理設備的普及,為直接面對消費者的血脂檢測產品創造了市場機遇,而診斷公司與醫療服務提供者之間的合作,則有望推動全球市場滲透和服務拓展。

本次調查的主要特點

  • 本報告對全球血脂檢查市場進行了詳細分析,以 2024 年為基準年,給出了預測期(2025-2032 年)內的市場規模(十億美元)和復合年成長率(%)。
  • 我們將重點介紹各個細分市場的潛在商機,並說明該市場具有吸引力的投資提案矩陣。
  • 該研究還提供了有關市場促進因素、阻礙因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本研究根據以下參數介紹了全球血脂檢查市場主要企業的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 這份全球血脂檢查市場報告的目標受眾是該行業的各類相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過各種用於分析全球血脂檢查市場的策略矩陣輕鬆做出決策。

目錄

第1章 研究目標與前提條件

  • 調查目的
  • 先決條件
  • 簡稱

第2章 市場範圍

  • 報告概述
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、監理及趨勢分析

  • 市場動態
  • 促進要素
  • 抑制因素
  • 機會
  • 影響分析
  • 重大進展
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特分析
  • 併購趨勢
  • 產業趨勢

4. 2020-2032年全球血脂檢查市場(依檢測類型分類)

  • 標準血脂譜
  • 進階脂質檢測

5. 2020-2032年全球血脂檢查市場(依產品類型分類)

  • 裝置
  • 試劑和試劑盒

6. 2020-2032年全球血脂檢查市場(依應用領域分類)

  • 高血脂症
  • 高三酸甘油脂血症
  • 遺傳性高膽固醇症
  • 低載脂蛋白血症
  • 坦齊爾氏症
  • 動脈粥狀硬化
  • 其他血脂異常症

7. 2020-2032年全球血脂檢查市場(依配方類型分類)

  • 處方箋測試
  • 非處方藥 (OTC) 檢測

8. 2020-2032年全球血脂檢查市場(依最終用戶分類)

  • 醫院
  • 專科診所
  • 病理檢查室
  • 診斷診所
  • 門診手術中心
  • 居家醫療機構
  • 學術和研究機構

9. 2020-2032年全球血脂檢查市場(按地區分類)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 亞太其他地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第10章 競爭格局

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • Hoffmann-La Roche Ltd.
  • Randox Laboratories Ltd.
  • Thermo Fisher Scientific Inc.
  • Siemens Healthcare GmbH
  • Bio-Rad Laboratories Inc.
  • Nova Biomedical Corporation
  • SD Biosensor, Inc.
  • PTS Diagnostics
  • Horiba Medical
  • Elitech Group
  • Menarini Group
  • VivaChek Biotech(Hangzhou)Co., Ltd.
  • Mico Bio Med

第11章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第12章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI8860

Lipid Panel Test Market is estimated to be valued at USD 11.82 Bn in 2025 and is expected to reach USD 20.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.82 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.90% 2032 Value Projection: USD 20.13 Bn

The global lipid panel test market represents a critical segment of the clinical diagnostics industry, encompassing comprehensive blood tests that measure various cholesterol and triglyceride levels to assess cardiovascular disease risk. Lipid panel tests, also known as lipid profiles or lipograms, evaluate total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides in patients' blood samples.

These diagnostic assessments serve as fundamental screening tools for healthcare providers to identify individuals at risk of developing atherosclerosis, coronary artery disease, and other cardiovascular complications. The market encompasses various testing methodologies including enzymatic assays, homogeneous assays, and advanced automated analyzers deployed across hospitals, diagnostic laboratories, and point-of-care settings.

With the increasing prevalence of lifestyle-related diseases, aging populations, and growing awareness of preventive healthcare measures, the demand for lipid panel testing continues to expand globally. The integration of technological advancements such as high-throughput analyzers, portable testing devices, and digital health platforms has revolutionized the accessibility and efficiency of lipid testing procedures, making them more convenient for both healthcare providers and patients across diverse healthcare settings worldwide.

Market Dynamics

The global lipid panel test market is primarily driven by the escalating prevalence of cardiovascular diseases, diabetes, and obesity worldwide, creating substantial demand for regular lipid monitoring and screening procedures. The aging global population, particularly in developed countries, significantly contributes to market growth as elderly individuals require frequent cardiovascular risk assessments and lipid profile monitoring.

Technological advancements in diagnostic equipment, including the development of high-throughput automated analyzers, point-of-care testing devices, and portable lipid testing solutions, enhance testing accuracy, efficiency, and accessibility, thereby driving market expansion. Government initiatives promoting preventive healthcare measures, cardiovascular disease screening programs, and healthcare awareness campaigns further stimulate market demand.

However, the market faces certain restraints including high costs associated with advanced diagnostic equipment and testing procedures, which may limit accessibility in resource-constrained healthcare settings and developing regions. Stringent regulatory requirements for diagnostic device approvals, quality control standards, and laboratory certifications create barriers to market entry and increase compliance costs for manufacturers. Limited healthcare infrastructure, shortage of skilled laboratory professionals, and inadequate reimbursement policies in certain regions also hinder market growth.

Nevertheless, significant opportunities exist in emerging markets with expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness about cardiovascular health. The integration of artificial intelligence, machine learning algorithms, and telemedicine platforms presents opportunities for developing innovative lipid testing solutions and remote monitoring capabilities. The rising trend of home-based healthcare and self-monitoring devices creates potential for consumer-friendly lipid testing products, while partnerships between diagnostic companies and healthcare providers can facilitate market penetration and service expansion globally.

Key Features of the Study

  • This report provides in-depth analysis of the global lipid panel test market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lipid panel test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Beckman Coulter Inc., F. Hoffmann-La Roche Ltd., Randox Laboratories Ltd., Thermo Fisher Scientific Inc., Siemens Healthcare GmbH, Bio-Rad Laboratories Inc., Nova Biomedical Corporation, SD Biosensor, Inc., PTS Diagnostics, Horiba Medical, Elitech Group, Menarini Group, VivaChek Biotech (Hangzhou) Co., Ltd., and Mico Bio Med.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lipid panel test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lipid panel test market

Market Segmentation

  • Test Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Standard Lipid Profile
    • Total Cholesterol
    • Triglycerides
    • Low-Density Lipoprotein (LDL) Cholesterol
    • High-Density Lipoprotein (HDL) Cholesterol
    • Advanced Lipid Testing
    • LDL Particle Number (LDL-P)
    • Apolipoprotein B (ApoB)
    • Lipoprotein(a) (Lp(a))
    • Others (HDL Subclasses, VLDL Cholesterol etc.)
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Devices
    • Automated Analyzers
    • Point-of-Care Testing Devices
    • Spectrophotometers
    • Others
    • Reagents and Kits
    • Cholesterol Test Kits
    • HDL and LDL Kits
    • Triglyceride Test Kits
    • Test Strips
    • Other Product Types
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Hyperlipidemia
    • Hypertriglyceridemia
    • Familial Hypercholesterolemia
    • Hypo Lipoproteinemia
    • Tangier Disease
    • Atherosclerosis
    • Other Lipid Disorders
  • Prescription Mode Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription-Based Testing
    • Over-the-Counter (OTC) Testing
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals
    • Specialty Clinics
    • Pathology Laboratories
    • Diagnostic Clinics
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Academic and Research Institutes
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Hoffmann-La Roche Ltd.
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare GmbH
    • Bio-Rad Laboratories Inc.
    • Nova Biomedical Corporation
    • SD Biosensor, Inc.
    • PTS Diagnostics
    • Horiba Medical
    • Elitech Group
    • Menarini Group
    • VivaChek Biotech (Hangzhou) Co., Ltd.
    • Mico Bio Med

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lipid Panel Test Market, By Test Type
    • Global Lipid Panel Test Market, By Product Type
    • Global Lipid Panel Test Market, By Application
    • Global Lipid Panel Test Market, By Prescription Mode
    • Global Lipid Panel Test Market, By End User
    • Global Lipid Panel Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lipid Panel Test Market, By Test Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Standard Lipid Profile
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Total Cholesterol
      • Triglycerides
      • Low-Density Lipoprotein (LDL) Cholesterol
      • High-Density Lipoprotein (HDL) Cholesterol
  • Advanced Lipid Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • LDL Particle Number (LDL-P)
      • Apolipoprotein B (ApoB)
      • Lipoprotein(a) (Lp(a))
      • Others (HDL Subclasses, VLDL Cholesterol etc.)

5. Global Lipid Panel Test Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Automated Analyzers
      • Point-of-Care Testing Devices
      • Spectrophotometers
      • Others
  • Reagents and Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Cholesterol Test Kits
      • HDL and LDL Kits
      • Triglyceride Test Kits
      • Test Strips
      • Other Product Types

6. Global Lipid Panel Test Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hyperlipidemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hypertriglyceridemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Familial Hypercholesterolemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hypo Lipoproteinemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tangier Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Atherosclerosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Lipid Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lipid Panel Test Market, By Prescription Mode, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription-Based Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter (OTC) Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lipid Panel Test Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pathology Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Lipid Panel Test Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Test Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Prescription Mode, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beckman Coulter Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Randox Laboratories Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthcare GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nova Biomedical Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • SD Biosensor, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PTS Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Horiba Medical
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elitech Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Menarini Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • VivaChek Biotech (Hangzhou) Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mico Bio Med
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us